Despite hemp and hemp-derived products being removed from Schedule 1, CBD from cannabis remains banned.
The developments also mean CBD infused food and drinks could be hitting American shelves in the near future, but currently CBD remains a pharmaceutical ingredient.
In a statement regarding the 2018 Farm Bill, FDA Commissioner Scott Gottlieb clarified that CBD is currently only approved for use in certain drugs. CBD can relax users but doesn’t get them high.
The FDA has said it will look into whether it could allow the use of a drug ingredient in food, holding a public meeting “in the near future” to determine next steps.
For now, the FDA will continue to stop companies from marketing CBD as a drug or disease-thwarting dietary supplement without vetting and approval by the agency, the statement said.
Coca-Cola released a statement saying they will wait to market CBD drinks after the rules are clear.
NORML Deputy Director, Paul Armentano, released a press release describing the Bill’s provisions as a significant step in the history of cannabis in the USA:
“The significance of this law change should not be underemphasized.
“This law marks the first change in the federal classification of the cannabis plant since it was initially classified as a schedule I controlled substance by Congress in 1970, and paves the way for the first federally-sanctioned commercial hemp grows since World War II.”